《大行報告》花旗下調長建(01038.HK)目標價至51.5元 評級「買入」
花旗發表報告指,由於貨幣貶值,將長江基建(01038.HK)今年至2024年各年盈利預測分別下調6.2%、6.9%及6.8%,股份目標價由57元降至51.5元,反映盈利削減及利率上升後折讓率擴大。
該行同時重申對長建股份「買入」評級,認為香港重新開放,應可使集團明年有更好機會進行提高每股收益的併購;加息亦應有利緩和競購新資產的競爭;加上英國電網的回報重置風險已經降低。
花旗提到,長建估值相當於預測明年市盈率12.5倍、預測市賬率0.8倍及收益率6.3%,是具有吸引力。於長建及電能實業(00006.HK)之間,該行更看好前者,主要期待有更多的收購催化劑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.